A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome

NCT04462770 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Dravet Syndrome

Interventions

DRUG: Clemizole HCl
DRUG: Placebo

Sponsor

Epygenix

Collaborators

[object Object]